Immunopathologists are medical specialists who investigate diseases caused by abnormal immune responses, including autoimmune disorders, immunodeficiencies, hypersensitivity reactions, and immune-related complications of infections. They analyze tissue samples, blood, and other bodily fluids to detect immune system dysfunction and identify underlying mechanisms driving disease progression. By interpreting complex immunologic tests—such as immunohistochemistry, flow cytometry, and serologic assays—they help diagnose conditions like lupus, rheumatoid arthritis, immunodeficiency syndromes, and immune-mediated complications of infectious diseases.
In infectious disease settings, Immunopathologists play a critical role in understanding how the immune system responds to pathogens, differentiating between protective and pathological responses. Their expertise guides therapeutic decisions, including the use of immunomodulators, monoclonal antibodies, and vaccines. They also contribute to research on emerging infections, post-infectious syndromes, and long-term immune sequelae. As immune-based therapies and diagnostics become more integrated into clinical care, the role of Immunopathologists is increasingly essential to personalized medicine. Their work bridges the gap between immunology and pathology, ensuring accurate diagnosis and optimal treatment strategies for complex immune-related conditions. They are also vital contributors to translational research, helping bring laboratory discoveries into clinical application for improved patient outcomes. Through multidisciplinary collaboration, they help shape clinical guidelines and advance the development of novel immunotherapeutics. Their insights also support vaccine safety monitoring and immunological assessments in large-scale public health initiatives.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain